کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9901484 | 1545423 | 2005 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
SGFDNSHASSIFETECCFUenterotoxigenic Escherichia coli - Esterichia coli EnterotoxigenicOral administration - اداره دهان و دندانEscherichia coli - اشریشیا کُلیDrug delivery - تحویل(رهایش) داروDegree of substitution - درجه جایگزینیSimulated intestinal fluid - شبیه سازی مایع رودهsimulated gastric fluid - شبیه سازی مایع معدهGastric resistance - مقاومت معدهHigh amylose starch - نشاسته آمیلوز بالاCompression force - نیروی فشرده سازیcolony forming units - واحدهای تشکیل دهنده کلنیVaccin - واکسنProbiotics - پروبیوتیکcarboxymethyl - کربوکسی متیل
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
بیوتکنولوژی یا زیستفناوری
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Carboxymethyl high amylose starch (CM-HAS) is proposed as a novel excipient for oral tablet formulation of bioactive agents ensuring their protection in the stomach and delivery in the intestine. Three variants of CM-HAS, with different degrees of substitution, were synthesized by starch treatment with various amounts of monochloroacetic acid. The products were dried in powder form and tablets were obtained by direct compression of mixed powders of polymeric excipient and lyophilized Escherichia coli (E. coli) bacteria. Dosage forms of CM-HAS are unswollen and compact in acidic medium, ensuring protection of active agents against acidity. Release of bacteria from CM-HAS tablets is based on the fast swelling of the tablets during the passage from gastric acidity to alkaline intestinal medium, enzymatic hydrolysis triggering their rapid, almost total dissolution. The bacteria thus formulated displayed higher survival rates in acidic gastric conditions and for longer periods than the free bacteria or than the bacteria formulated with the non-derivatized starch. The CM-HAS selected matrix also assured a good viability of bacteria after 6 months under refrigeration.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 60, Issue 1, May 2005, Pages 53-60
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 60, Issue 1, May 2005, Pages 53-60
نویسندگان
Carmen Calinescu, Jérôme Mulhbacher, Ãric Nadeau, John Morris Fairbrother, Mircea Alexandru Mateescu,